Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1620579-34-1

Post Buying Request

1620579-34-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1620579-34-1 Usage

General Description

"(S)-7-chloro-2-methyl-2,3-dihydroimidazo[1,2-c]pyrimidin-5(1H)-one" is a chemical compound with a complex and specific structure. It belongs to the class of imidazopyrimidine derivatives and has a stereospecific configuration denoted by the "(S)" prefix. The compound contains a chlorine atom and a methyl group, and its heterocyclic ring structure consists of nitrogen and carbon atoms. It may have potential applications in pharmaceutical and medicinal chemistry due to its unique structure and properties. Further research and exploration of this compound could lead to its use in the development of novel drugs or therapeutic agents.

Check Digit Verification of cas no

The CAS Registry Mumber 1620579-34-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,2,0,5,7 and 9 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1620579-34:
(9*1)+(8*6)+(7*2)+(6*0)+(5*5)+(4*7)+(3*9)+(2*3)+(1*4)=161
161 % 10 = 1
So 1620579-34-1 is a valid CAS Registry Number.

1620579-34-1Relevant articles and documents

1,2,3,5-TETRAHYDROIMIDAZO[1,2-C]PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF DISEASES AND DISORDERS MEDIATED BY LP-PLA2

-

Page/Page column 24; 25, (2016/02/18)

The present invention relates to novel compounds that inhibit Lp‐PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases or disorders associated with the activity of Lp‐PLAs

COMPOUNDS

-

Paragraph 0188; 0189; 0190, (2014/08/07)

The present invention relates to novel compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1620579-34-1